$15.62
At close: May 2 EDT
$15.60
-0.02-0.13%
Pre-Market: 4:00 AM EDT
Comments
Loading...
Teva Pharmaceutical Indus Stock Price, Quotes and Forecasts
TEVANYSE
Teva Pharmaceutical Indus (TEVA) Forecast
NewsEarningsTeva Pharmaceutical Indus (TEVA) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Teva Pharmaceutical Indus Stock Price, Quotes and Forecasts | NYSE:TEVA | Benzinga
Explore Teva Pharmaceutical Indus stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for TEVA.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Teva Pharmaceutical Indus (TEVA) stock?
You can purchase shares of Teva Pharmaceutical Indus (NYSE:TEVA) through any online brokerage.
Who are Teva Pharmaceutical Indus (TEVA) competitors?
Other companies in Teva Pharmaceutical Indus’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Verona Pharma (NASDAQ:VRNA) and Novartis (NYSE:NVS).
What is the forecast, or price target, for Teva Pharmaceutical Indus (TEVA) stock?
Teva Pharmaceutical Indus has a consensus price target of $18.80.
What is the current price for Teva Pharmaceutical Indus (TEVA)?
The stock price for Teva Pharmaceutical Indus (NYSE: TEVA) is $15.6 last updated May 2, 2025 at 4:00 AM EDT.
Does Teva Pharmaceutical Indus (TEVA) pay a dividend?
A quarterly cash dividend of 0.09 per share of Class A Common Stock. The quarterly cash dividend was payable on December 12, 2017 to stockholders of record on November 28, 2017.
When is Teva Pharmaceutical Indus (NYSE:TEVA) reporting earnings?
Teva Pharmaceutical Indus’s Q2 earnings are confirmed for Wednesday, July 30, 2025.
Is Teva Pharmaceutical Indus (TEVA) going to split?
There is no upcoming split for Teva Pharmaceutical Indus.
What sector and industry does Teva Pharmaceutical Indus (TEVA) operate in?
Teva Pharmaceutical Indus is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
